InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+30.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Sukhtian Ghiath M., Director. Director active across 1 company, notably Outlook Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €19.9m. History available since 29 November 2021. The latest transaction was disclosed on 12 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sukhtian Ghiath M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,525,252 shares@ US$0.99Common StockSEC:0000899140-26-000894:0
Canonical exit: 10 Nov 2026 (T+90)
4,285,714 shares@ US$1.4011.5% of flowCommon StockSEC:0000947871-25-000571:0
3,458,571 shares@ US$2.5113.8% of flowCommon StockSEC:0000947871-25-000306:0
2,305,714 sharesCommon StockSEC:0000947871-24-000291:0
14,230,418 shares@ US$0.878419.2% of flowCommon StockSEC:0000947871-22-001263:0
27,982,529 sharesCommon StockSEC:0000947871-22-000751:0
2,500,000 shares@ US$1.256.1% of flowCommon StockSEC:0000947871-22-000124:0
16,000,000 shares@ US$1.2538.5% of flowCommon StockSEC:0000947871-21-001250:0
Canonical exit: 27 Feb 2022 (T+90)
8 of 8 declarations
About Sukhtian Ghiath M.
Ghiath M. Sukhtian is a Director at Outlook Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. His experience is valuable for the development of Outlook Therapeutics.
